US EditionF.N.B.: Q2 Earnings Snapshot
ABBOTT PARK, ILLINOIS, JUL 17 – Abbott Laboratories posted $1.78 billion profit and $11.14 billion revenue, exceeding analyst estimates, driven by strong sales in infant formula, medical devices, and drugs.
- At its Abbott Park, Illinois headquarters, Abbott Laboratories reported a second-quarter profit of $1.78 billion.
- As a maker of infant formula, medical devices and drugs, Abbott Laboratories posted revenue of $11.14 billion, surpassing analysts’ forecasts.
- Adjusted earnings per share of $1.26 topped the $1.25 analysts expected, confirming stronger profitability.
- During the same period, the S&P 500 index climbed 6.5%, while Abbott shares increased 16% since the start of the year.
- For the current quarter ending in September, Abbott expects earnings of $1.28 to $1.32 per share and full-year EPS of $5.10 to $5.20.
Insights by Ground AI
Does this summary seem wrong?
56 Articles
56 Articles
F.N.B.: Q2 Earnings Snapshot
LancasterOnline+2 Reposted by 2 other sources
F.N.B.: Q2 Earnings Snapshot
PITTSBURGH (AP) — PITTSBURGH (AP) — F.N.B. Corp. (FNB) on Thursday reported second-quarter earnings of $130.7 million.
·Lancaster, United States
Read Full Article
Coverage Details
Total News Sources56
Leaning Left8Leaning Right4Center18Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
L 27%
C 60%
13%
Factuality
To view factuality data please Upgrade to Premium
